Similar companies
Company | Business Outlook | |
---|---|---|
AmgenAMGN |
77 0% | |
Gilead SciencesGILD |
60 0% | |
Catalyst PharmaceuticalsCPRX |
100 0% | |
Inovio PharmaceuticalsINO |
23 0% | |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
Dec 2024 | 34 | |
Nov 2024 | 34 | |
Oct 2024 | 34 | |
Sep 2024 | 32 | |
Aug 2024 | 38 |
How do employees feel about the future at NovaBay Pharmaceuticals?
According to employees, the Business Outlook at NovaBay Pharmaceuticals is highly negative. This is reflected in the average rating of 34 out of 100, which is considered very low.
Analyzing Business Outlook, how is NovaBay Pharmaceuticals performing compared to its industry peers?
NovaBay Pharmaceuticals underperforms its industry peers when it comes to Business Outlook, ranking in the 34th percentile.
How has the business outlook at NovaBay Pharmaceuticals changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at NovaBay Pharmaceuticals.
Why is it important to track the business outlook at NovaBay Pharmaceuticals?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at NovaBay Pharmaceuticals.